{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T13:56:37Z","timestamp":1777730197941,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Interv Neuroradiol"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic subdural hematoma (CSDH) is increasingly treated with middle meningeal artery embolization (MMAE). This study evaluated MMAE using a precipitating hydrophobic injectable liquid low viscosity (PHIL-LV) liquid embolic agent under general anaesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive patients who underwent MMAE for CSDH with PHIL-LV at a single comprehensive neuroscience centre during a two-year period (2023\u20132025) were analysed. Patient clinical characteristics, imaging characteristics and procedural characteristics were recorded and described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-two patients (mean age 76\u2009\u00b1\u200913) were included in this study. Mean CSDH size was 18.4\u2009\u00b1\u20096.7\u2005mm; 9\/22 (40.9%) patients had a Charlson Comorbidity index &gt;4. MMA embolization was successful in all 22\/22 (100%) patients. Symptomatic improvement was observed in 14\/17 (82.4%) of patients. During mean follow up (10.7\u2009\u00b1\u20099.2 (range 1\u201336)) weeks, mean reduction in CSDH thickness was 12.1\u2009\u00b1\u20099.9\u2005mm; 13\/16 (81.3%) patients had at least partial radiologic resolution of CSDH. No patients required retreatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PHIL-LV MMAE was safe and effective for treatment of CSDH in this case series.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15910199251397148","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:32:15Z","timestamp":1763659935000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Middle meningeal artery embolization for chronic subdural hematoma using PHIL-LV: A case series"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1645-2258","authenticated-orcid":false,"given":"Rudy","family":"Goh","sequence":"first","affiliation":[{"name":"South Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Bacchi","sequence":"additional","affiliation":[{"name":"Adelaide Medical School, University of Adelaide, Adelaide SA, Australia"},{"name":"Department of Neurology and the Center for Genomic Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Scroop","sequence":"additional","affiliation":[{"name":"South Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Jukes","sequence":"additional","affiliation":[{"name":"South Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Taylor","sequence":"additional","affiliation":[{"name":"South Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Waters","sequence":"additional","affiliation":[{"name":"South Australian Medical Imaging Department, Royal Adelaide Hospital, Adelaide SA, Australia"},{"name":"Adelaide Medical School, University of Adelaide, Adelaide SA, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_3_2_2_2","article-title":"Middle meningeal artery embolization to treat chronic subdural hematoma","volume":"3","author":"Rudy RF","year":"2023","unstructured":"Rudy RF, Catapano JS, Jadhav AP, et al. Middle meningeal artery embolization to treat chronic subdural hematoma. Stroke Vasc Interv Neurol 2023; 3: e000490.","journal-title":"Stroke Vasc Interv Neurol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313472"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2401201"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409845"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-019-04161-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/15910199221104631"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/15910199231162665"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/1591019921996510"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1591019921990962"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/15910199221125977"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2023-020132"},{"key":"e_1_3_2_13_2","first-page":"98","article-title":"N-butyl cyanoacrylate embolotherapy: techniques, complications, and management","volume":"24","author":"Hill H","year":"2018","unstructured":"Hill H, Chick JFB, Hage A, et al. N-butyl cyanoacrylate embolotherapy: techniques, complications, and management. Diagn Interv Radiol Ank Turk 2018; 24: 98\u2013103.","journal-title":"Diagn Interv Radiol Ank Turk"},{"key":"e_1_3_2_14_2","article-title":"Middle meningeal artery embolization for chronic subdural hematoma: a review of established and emerging embolic agents","volume":"4","author":"Tudor T","year":"2024","unstructured":"Tudor T, et al. Middle meningeal artery embolization for chronic subdural hematoma: a review of established and emerging embolic agents. Stroke Vasc Interv Neurol 2024; 4: e000906.","journal-title":"Stroke Vasc Interv Neurol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/1591019918784915"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1039\/D0TB01576H"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-021-01066-6"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2021-018430"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chphma.2021.09.008"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomimetics7020077"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016185"}],"updated-by":[{"DOI":"10.1177\/15910199261444853","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000}}],"container-title":["Interventional Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15910199251397148","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15910199251397148","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15910199251397148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:57:45Z","timestamp":1777460265000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15910199251397148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":20,"alternative-id":["10.1177\/15910199251397148"],"URL":"https:\/\/doi.org\/10.1177\/15910199251397148","relation":{},"ISSN":["1591-0199","2385-2011"],"issn-type":[{"value":"1591-0199","type":"print"},{"value":"2385-2011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"15910199251397148"}}